Amyloid β Protein in Plasma as a Diagnostic Marker for Alzheimer’s Disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · see citing works

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · see citing works

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · see citing works

The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease

Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · see citing works

Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774 · see citing works

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478 · see citing works

An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp ₇₁₇ ) Mutants

Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471 · see citing works

The Clinical Diagnosis of Alzheimer's Disease

Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C. S., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,416 · see citing works

Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease

Motter, R., Vigo‐Pelfrey, C., Kholodenko, D., Barbour, R., Johnson‐Wood, K., Galasko, D., Chang, L., Miller, B., Clark, C., Green, R., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380413 · Cited by 701 · see citing works

Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome

Iwatsubo, T., Mann, D. M. A., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410370305 · Cited by 380 · see citing works

The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue

Tomita, T., Maruyama, K., Saido, T. C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Walter, J., Grünberg, J., Haass, C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2025 · Cited by 379 · see citing works

Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease

Arai, H., Terajima, M., Miura, M., Higuchi, S., Muramatsu, T., Machida, N., Seiki, H., Takase, S., Clark, C., Lee, V. M., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380414 · Cited by 314 · see citing works

Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells.

Asami-Odaka, A., Ishibashi, Y., Kikuchi, T., Kitada, C., & Suzuki, N. (1995) · Biochemistry · doi:10.1021/bi00032a022 · Cited by 153 · see citing works

The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43)

Kosaka, T., Imagawa, M., Seki, K., Arai, H., Sasaki, H., Tsuji, S., Asami-Odaka, A., Fukushima, T., Imai, K., & Iwatsubo, T. (1997) · Neurology · doi:10.1212/wnl.48.3.741 · Cited by 106 · see citing works

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-887 · Cited by 1,209 · see citing works

Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease

Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · see citing works

Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults

Reger, M. A., Watson, G. S., Green, P. S., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Cherrier, M. M., Schellenberg, G. D., Frey, W. H., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13309 · Cited by 518 · see citing works

Plasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk

Mayeux, R., Honig, L. S., Tang, M.-X., Manly, J., Stern, Y., Schupf, N., & Mehta, P. D. (2003) · Neurology · doi:10.1212/01.wnl.0000091890.32140.8f · Cited by 434 · see citing works

Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study

van Oijen, M., Hofman, A., Soares, H. D., Koudstaal, P. J., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70501-4 · Cited by 458 · see citing works

Diagnosis and treatment of dementia: 2. Diagnosis

Feldman, H., Jacova, C., Robillard, A., Garcia, A. A., Chow, T. W., BORRIE, M. J., Schipper, H. M., Blair, M., Kertesz, A., & Chertkow, H. M. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.070798 · Cited by 350 · see citing works

Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?

Sun, X., Steffens, D. C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Mwamburi, D. M., & Qiu, W. Q. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.542 · Cited by 174 · see citing works

Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging

Lui, J., Laws, S., Li, Q.-X., Villemagne, V., Ames, D., Brown, B., Bush, A., Ruyck, K. D., Dromey, J., Ellis, K., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-090249 · Cited by 141 · see citing works

Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms

Forloni, G., Terreni, L., Bertani, I., Fogliarino, S., Invernizzi, R. W., Assini, A., Ribizzi, G., Negro, A., Calabrese, E., & Volonté, M. A. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00076-3 · Cited by 132 · see citing works

Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD

Schipper, H. M., Chertkow, H. M., Mehindate, K., Frankel, D., Melmed, C., & Bergman, H. (2000) · Neurology · doi:10.1212/wnl.54.6.1297 · Cited by 117 · see citing works

In Salvia miltiorrhiza, phenolic acids possess protective properties against amyloid β-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors

Zhou, Y., Li, W., Xu, L., & Chen, L. (2011) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2011.02.006 · Cited by 117 · see citing works

Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897

Anderson, J. J., Holtz, G., Baskin, P. P., Turner, M., Rowe, B. A., Wang, B., Kounnas, M. Z., Lamb, B. T., Barten, D. M., Felsenstein, K. M., et al. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.11.015 · Cited by 92 · see citing works

Autoantibodies to Redox-modified Oligomeric Aβ Are Attenuated in the Plasma of Alzheimer's Disease Patients

Moir, R. D., Tseitlin, K. A., Soscia, S. J., Hyman, B. T., Irizarry, M. C., & Tanzi, R. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414176200 · Cited by 88 · see citing works

Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease

Kulstad, J. J., Green, P. S., Cook, D. G., Watson, G. S., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Rhoads, K., Mehta, P. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000216274.58185.09 · Cited by 82 · see citing works

Protective effects of Eucommia ulmoides Oliv. bark and leaf on amyloid β-induced cytotoxicity

Zhou, Y., Liang, M., Li, W., Li, K., Li, P., Hu, Y., & Zhong-lin, Y. (2009) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2009.05.012 · Cited by 60 · see citing works

Suppressed expression of nicotinic acetylcholine receptors by nanomolar β-amyloid peptides in PC12 cells

Guan, Z. Z., Miao, H., Tian, J., Unger, C., Nordberg, A. K., & Zhang, X. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100017 · Cited by 56 · see citing works

Treatment with the Selective Muscarinic Agonist Talsaclidine Decreases Cerebrospinal Fluid Levels of Total Amyloid β‐Peptide in Patients with Alzheimer's Disease

Hock, C., Maddalena, A. S., Heuser, I., Naber, D., Oertel, W. H., von der Kammer, H., Wienrich, M., Raschig, A., Deng, M., Growdon, J. H., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06937.x · Cited by 54 · see citing works

Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study

Hilal, S., Wolters, F. J., Verbeek, M. M., Vanderstichele, H., Ikram, M. K., Stoops, E., Ikram, M. A., & Vernooij, M. W. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0395-6 · Cited by 52 · see citing works

Maximizing the Potential of Plasma Amyloid-Beta as a Diagnostic Biomarker for Alzheimer’s Disease

Oh, E. S., Troncoso, J. C., & Tucker, S. M. F. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8035-0 · Cited by 35 · see citing works

Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease

Levy, S., McConville, M., Lazaro, G. A., & Averback, P. (2007) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20159 · Cited by 32 · see citing works

Plasma Aβ: A Possible Missing Link Between Alzheimer Disease and Diabetes

Sato, N., & Morishita, R. (2013) · Diabetes · doi:10.2337/db12-1549 · Cited by 30 · see citing works

Plasma β-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease

Takeda, S., Sato, N., Rakugi, H., & Morishita, R. (2010) · Molecular BioSystems · doi:10.1039/c003148h · Cited by 30 · see citing works

Oral Glucose Loading Modulates Plasma β-Amyloid Level in Alzheimer’s Disease Patients: Potential Diagnostic Method for Alzheimer’s Disease

Takeda, S., Sato, N., Uchio‐Yamada, K., Yu, H., Moriguchi, A., Rakugi, H., & Morishita, R. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000338704 · Cited by 29 · see citing works

The Relationship of Plasma Aβ Levels to Dementia in Aging Individuals With Down Syndrome

Matsuoka, Y., Andrews, H., Becker, A. G., Gray, A. J., Mehta, P. D., Sano, M. C., Dalton, A. J., & Aisen, P. S. S. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181aba61e · Cited by 29 · see citing works

Elevation of plasma β-amyloid level by glucose loading in Alzheimer mouse models

Takeda, S., Sato, N., Uchio‐Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H., & Morishita, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.037 · Cited by 25 · see citing works

The role of biologic markers in the diagnosis of Alzheimer's disease

Schipper, H. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.07.015 · Cited by 26 · see citing works

Habitual Aerobic Exercise Diminishes the Effects of Sarcopenia in Senescence-Accelerated Mice Prone8 Model

Aoki, K., Konno, M., Honda, K., Abe, T., Nagata, T., Takehara, M., Sugasawa, T., Takekoshi, K., & Ohmori, H. (2020) · Geriatrics · doi:10.3390/geriatrics5030048 · Cited by 17 · see citing works

Can Chiroptical Spectroscopy be Used for the Analysis of Blood Plasma?

Tatarkovič, M., Fišar, Z., Raboch, J., Jirák, R., & Setnička, V. (2012) · Chirality · doi:10.1002/chir.22063 · Cited by 17 · see citing works

Plasma amyloid-β, Aβ1-42, load is reduced by haemodialysis

Rubio, I., Caramelo, C. A., Gil, A., López, M. D., & de Yébenes, J. G. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10413 · Cited by 13 · see citing works

The relationship between plasma amyloid-β peptides and the medial temporal lobe in the homebound elderly

Sun, X., Bhadelia, R. A., Liebson, E. S., Bergethon, P. R., Folstein, M. F., Zhu, J., Mwamburi, D. M., Patz, S., & Qiu, W. Q. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2568 · Cited by 12 · see citing works

Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review

Avila-Vazquez, M., Altamirano-Bustamante, N. F., & Altamirano‐Bustamante, M. M. (2017) · Molecules · doi:10.3390/molecules23010079 · Cited by 10 · see citing works

Biological Markers and Alzheimer Disease: A Canadian Perspective

Schipper, H. M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/978182 · Cited by 8 · see citing works

a prospective case-cohort study

van Oijen, M., Albert Hofman, D., Breteler, M. M. B., Koudstaal, P. J., & Soares, H. D. (2006) · Cited by 5 · see citing works

Peripheral Markers of Alzheimer’s

Percy, M. E., Andrews, D. F., & Potter, H. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_9 · Cited by 3 · see citing works

Incidental Finding: Urine Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP) and Serum Vitamin D25

Song, C., Li, F., Wang, L., Shi, Y., & Shen, Z. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220165 · Cited by 1 · see citing works

Integrating Neuroimaging and Genetics Data in a Bioinformatics-based Approach for the Study of Alzheimer’s Disease

Patel, S. (2019) · TSpace (University of Toronto)

Untitled work

(1999) · doi:10.1002/1531-8249(199904)45:4

In Salvia miltiorrhiza, phenolic acids possess protective properties against amyloid β-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors

Zhou, Y., Li, W., Xu, L., & Chen, L. (2011) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2011.02.006 · Cited by 117 · see citing works

Neuroprotective effects of the ethanol extract of Salvia miltiorrhiza in Northern Vietnam against amyloid beta25-35-induced learning and memory impairment in vivo and cytotoxicity in vitro

Tran, T. L., Nguyen, T. H., Pham, N. H. T., Phuong, T. T., Nguyen, T. T. H., Tran, H. L., & Dao, T. V. (2021) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2021.03.19.140 · Cited by 1 · see citing works

Ethnomedicinal Plants with Protective Effects against Beta-Amyloid Peptide (Aβ)1-42 Indicate Therapeutic Potential in a New In Vivo Model of Alzheimer’s Disease

Althobaiti, N. A., Menaa, F., Dalzell, J. J., Albalawi, A. E., Ismail, H., Alghuthaymi, M. A., Aldawsari, R. D., Iqbal, H., McAlinney, C., & Green, B. D. (2022) · Antioxidants · doi:10.3390/antiox11101865 · Cited by 20 · see citing works

Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-β peptide

Irie, Y., & Keung, W. M. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04050-7 · Cited by 80 · see citing works

Inhibitory Effects of Extract of Rosae Rugosae Flos on the Acetylcholinesterase, β-secretase, and β-amyloid Aggregation

Kim, H. S., Kim, J. E., & Leem, J.-Y. (2016) · 동의생리병리학회지 · doi:10.15188/kjopp.2016.02.30.1.33 · Cited by 1 · see citing works